Status:
UNKNOWN
Study of Satisfaction of Patients and Care Providers for an Alternate Follow-up With In-hospital Consults and Tele-consult for Patients With Cystic Fibrosis
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The pandemic forced us to develop home follow-up for patients with chronical diseases . In the same time, the new era of treatment for cystic fibrosis considerably improves the health of patients with...
Eligibility Criteria
Inclusion
- patients with cystic fibrosis
- Patients treated with Kaftrio® since one year
- autonomous patients
- patients without cognitive disorders
- Patients voluntary for this follow up
- patients with two tele-communication tools
- patients with FEV1\>50%
- patients with less of 2 antibiotics cure per year
Exclusion
- all transplanted patients
- Pregnant patients
- Particular follow up needed in-hospital consult
- Persons deprived of their liberty by a judicial or administrative decision
- Persons subject to psychiatric care
- Persons admitted to a health or social establishment for purposes other than research
- Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
Key Trial Info
Start Date :
March 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05249322
Start Date
March 31 2022
End Date
March 31 2024
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Lyon Sud
Pierre-Bénite, France, 69 495